Smoldering Multiple Myeloma — Trials

Smoldering Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 34
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: Dana-Farber Cancer Institute
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05047107	Biology and Genetics of Smouldering Myeloma(COSMOS)	unknown	—	500	University College, LondonOTHER	1	Sep 16, 2021	clinicaltrials
NCT04727294	MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey	unknown	—	1,500	HealthTree FoundationOTHER	1	Aug 4, 2021	clinicaltrials